nodes	percent_of_prediction	percent_of_DWPC	metapath
Metoclopramide—HTR3A—migraine	0.511	1	CbGaD
Metoclopramide—DRD3—Amitriptyline—migraine	0.0813	0.321	CbGbCtD
Metoclopramide—CHRM1—Amitriptyline—migraine	0.0511	0.202	CbGbCtD
Metoclopramide—DRD2—Amitriptyline—migraine	0.0476	0.188	CbGbCtD
Metoclopramide—CYP2D6—Timolol—migraine	0.0223	0.0881	CbGbCtD
Metoclopramide—CYP2D6—Propranolol—migraine	0.0199	0.0785	CbGbCtD
Metoclopramide—CYP2D6—Amitriptyline—migraine	0.0172	0.0679	CbGbCtD
Metoclopramide—CYP2D6—Verapamil—migraine	0.0136	0.0539	CbGbCtD
Metoclopramide—HTR3A—cranial nerve—migraine	0.00252	0.171	CbGeAlD
Metoclopramide—HTR3A—nerve—migraine	0.00129	0.0879	CbGeAlD
Metoclopramide—CYP11B2—cardiovascular system—migraine	0.000944	0.0642	CbGeAlD
Metoclopramide—HTR4—brain—migraine	0.000823	0.0559	CbGeAlD
Metoclopramide—DRD2—nerve—migraine	0.000791	0.0537	CbGeAlD
Metoclopramide—Proparacaine—SCN1A—migraine	0.000697	0.107	CrCbGaD
Metoclopramide—Amisulpride—HTR2B—migraine	0.000688	0.106	CrCbGaD
Metoclopramide—Oxybuprocaine—SCN1A—migraine	0.000637	0.0977	CrCbGaD
Metoclopramide—HTR3A—trigeminal ganglion—migraine	0.000627	0.0426	CbGeAlD
Metoclopramide—Proparacaine—SCN2A—migraine	0.000614	0.0942	CrCbGaD
Metoclopramide—Oxybuprocaine—SCN2A—migraine	0.000562	0.0862	CrCbGaD
Metoclopramide—HTR3A—brainstem—migraine	0.000555	0.0377	CbGeAlD
Metoclopramide—Chloroprocaine—HTR3A—migraine	0.000495	0.076	CrCbGaD
Metoclopramide—Procaine—HTR3A—migraine	0.000472	0.0725	CrCbGaD
Metoclopramide—Amenorrhoea—Gabapentin—migraine	0.000455	0.00371	CcSEcCtD
Metoclopramide—Hallucination—Amitriptyline—migraine	0.000454	0.0037	CcSEcCtD
Metoclopramide—DRD3—head—migraine	0.000443	0.0301	CbGeAlD
Metoclopramide—Atrioventricular block—Timolol—migraine	0.000442	0.00361	CcSEcCtD
Metoclopramide—Rash maculo-papular—Valproic Acid—migraine	0.000438	0.00358	CcSEcCtD
Metoclopramide—Respiratory failure—Timolol—migraine	0.000437	0.00357	CcSEcCtD
Metoclopramide—Neutropenia—Propranolol—migraine	0.000434	0.00354	CcSEcCtD
Metoclopramide—Erectile dysfunction—Propranolol—migraine	0.000427	0.00349	CcSEcCtD
Metoclopramide—Amisulpride—HTR7—migraine	0.000426	0.0653	CrCbGaD
Metoclopramide—Dyskinesia—Gabapentin—migraine	0.000425	0.00347	CcSEcCtD
Metoclopramide—Cisapride—HTR3A—migraine	0.000421	0.0646	CrCbGaD
Metoclopramide—DRD3—nervous system—migraine	0.00042	0.0286	CbGeAlD
Metoclopramide—Bronchospasm—Verapamil—migraine	0.00042	0.00343	CcSEcCtD
Metoclopramide—Depression—Propranolol—migraine	0.000412	0.00337	CcSEcCtD
Metoclopramide—Cisapride—HTR2B—migraine	0.000412	0.0632	CrCbGaD
Metoclopramide—Atrioventricular block—Gabapentin—migraine	0.000412	0.00336	CcSEcCtD
Metoclopramide—Respiratory failure—Gabapentin—migraine	0.000407	0.00332	CcSEcCtD
Metoclopramide—DRD3—central nervous system—migraine	0.000405	0.0275	CbGeAlD
Metoclopramide—Pollakiuria—Verapamil—migraine	0.000394	0.00322	CcSEcCtD
Metoclopramide—Erectile dysfunction—Verapamil—migraine	0.000393	0.00321	CcSEcCtD
Metoclopramide—Delirium—Topiramate—migraine	0.000391	0.00319	CcSEcCtD
Metoclopramide—CYP17A1—head—migraine	0.000391	0.0266	CbGeAlD
Metoclopramide—Urinary incontinence—Gabapentin—migraine	0.000386	0.00315	CcSEcCtD
Metoclopramide—Agranulocytosis—Propranolol—migraine	0.000386	0.00315	CcSEcCtD
Metoclopramide—Amenorrhoea—Topiramate—migraine	0.000383	0.00313	CcSEcCtD
Metoclopramide—Drowsiness—Verapamil—migraine	0.00038	0.00311	CcSEcCtD
Metoclopramide—Fluid retention—Gabapentin—migraine	0.000379	0.0031	CcSEcCtD
Metoclopramide—Bradycardia—Propranolol—migraine	0.000378	0.00309	CcSEcCtD
Metoclopramide—Tremor—Amitriptyline—migraine	0.000372	0.00304	CcSEcCtD
Metoclopramide—Jaundice—Verapamil—migraine	0.000371	0.00303	CcSEcCtD
Metoclopramide—CYP17A1—nervous system—migraine	0.00037	0.0252	CbGeAlD
Metoclopramide—Hallucination—Propranolol—migraine	0.000369	0.00302	CcSEcCtD
Metoclopramide—Agitation—Amitriptyline—migraine	0.000365	0.00298	CcSEcCtD
Metoclopramide—Rash maculo-papular—Gabapentin—migraine	0.000363	0.00297	CcSEcCtD
Metoclopramide—Dyskinesia—Topiramate—migraine	0.000358	0.00292	CcSEcCtD
Metoclopramide—Visual impairment—Propranolol—migraine	0.000358	0.00292	CcSEcCtD
Metoclopramide—Gynaecomastia—Gabapentin—migraine	0.000358	0.00292	CcSEcCtD
Metoclopramide—CYP17A1—central nervous system—migraine	0.000357	0.0242	CbGeAlD
Metoclopramide—Leukopenia—Amitriptyline—migraine	0.000355	0.0029	CcSEcCtD
Metoclopramide—Palpitations—Amitriptyline—migraine	0.000351	0.00286	CcSEcCtD
Metoclopramide—Bradycardia—Verapamil—migraine	0.000348	0.00284	CcSEcCtD
Metoclopramide—Atrioventricular block—Topiramate—migraine	0.000347	0.00283	CcSEcCtD
Metoclopramide—CHRM1—cardiovascular system—migraine	0.000344	0.0234	CbGeAlD
Metoclopramide—Convulsion—Amitriptyline—migraine	0.000344	0.00281	CcSEcCtD
Metoclopramide—Cardiac failure congestive—Timolol—migraine	0.000344	0.00281	CcSEcCtD
Metoclopramide—Hypertension—Amitriptyline—migraine	0.000343	0.0028	CcSEcCtD
Metoclopramide—DRD2—brainstem—migraine	0.000339	0.0231	CbGeAlD
Metoclopramide—Anxiety—Amitriptyline—migraine	0.000337	0.00275	CcSEcCtD
Metoclopramide—Visual impairment—Verapamil—migraine	0.000329	0.00269	CcSEcCtD
Metoclopramide—Visual disturbance—Timolol—migraine	0.000329	0.00268	CcSEcCtD
Metoclopramide—Confusional state—Amitriptyline—migraine	0.000327	0.00267	CcSEcCtD
Metoclopramide—Urinary incontinence—Topiramate—migraine	0.000325	0.00265	CcSEcCtD
Metoclopramide—Oedema—Amitriptyline—migraine	0.000324	0.00265	CcSEcCtD
Metoclopramide—DRD3—brain—migraine	0.000321	0.0218	CbGeAlD
Metoclopramide—Cardiac failure congestive—Gabapentin—migraine	0.00032	0.00261	CcSEcCtD
Metoclopramide—Fluid retention—Topiramate—migraine	0.000319	0.00261	CcSEcCtD
Metoclopramide—Flushing—Verapamil—migraine	0.000317	0.00259	CcSEcCtD
Metoclopramide—Tachycardia—Amitriptyline—migraine	0.000316	0.00258	CcSEcCtD
Metoclopramide—HTR3A—head—migraine	0.000307	0.0208	CbGeAlD
Metoclopramide—Atrial fibrillation—Gabapentin—migraine	0.000306	0.0025	CcSEcCtD
Metoclopramide—Rash maculo-papular—Topiramate—migraine	0.000306	0.0025	CcSEcCtD
Metoclopramide—Renal impairment—Gabapentin—migraine	0.000305	0.00249	CcSEcCtD
Metoclopramide—Hypotension—Amitriptyline—migraine	0.000303	0.00247	CcSEcCtD
Metoclopramide—Agitation—Propranolol—migraine	0.000297	0.00243	CcSEcCtD
Metoclopramide—Cardiac arrest—Timolol—migraine	0.000296	0.00242	CcSEcCtD
Metoclopramide—Insomnia—Amitriptyline—migraine	0.000293	0.00239	CcSEcCtD
Metoclopramide—Procainamide—SCN1A—migraine	0.000293	0.0449	CrCbGaD
Metoclopramide—HTR3A—nervous system—migraine	0.000291	0.0198	CbGeAlD
Metoclopramide—Somnolence—Amitriptyline—migraine	0.000288	0.00235	CcSEcCtD
Metoclopramide—Muscle spasms—Verapamil—migraine	0.000286	0.00233	CcSEcCtD
Metoclopramide—CYP17A1—brain—migraine	0.000283	0.0192	CbGeAlD
Metoclopramide—Neutropenia—Valproic Acid—migraine	0.000283	0.00231	CcSEcCtD
Metoclopramide—Convulsion—Propranolol—migraine	0.00028	0.00229	CcSEcCtD
Metoclopramide—HTR3A—central nervous system—migraine	0.00028	0.019	CbGeAlD
Metoclopramide—Pollakiuria—Valproic Acid—migraine	0.000279	0.00228	CcSEcCtD
Metoclopramide—Fatigue—Amitriptyline—migraine	0.000279	0.00228	CcSEcCtD
Metoclopramide—Tremor—Verapamil—migraine	0.000278	0.00227	CcSEcCtD
Metoclopramide—Cardiac arrest—Gabapentin—migraine	0.000276	0.00225	CcSEcCtD
Metoclopramide—Agitation—Verapamil—migraine	0.000273	0.00223	CcSEcCtD
Metoclopramide—Angioedema—Verapamil—migraine	0.000272	0.00222	CcSEcCtD
Metoclopramide—Drowsiness—Valproic Acid—migraine	0.00027	0.0022	CcSEcCtD
Metoclopramide—Asthma—Timolol—migraine	0.000269	0.0022	CcSEcCtD
Metoclopramide—Depression—Valproic Acid—migraine	0.000269	0.0022	CcSEcCtD
Metoclopramide—Feeling abnormal—Amitriptyline—migraine	0.000267	0.00218	CcSEcCtD
Metoclopramide—Bronchospasm—Timolol—migraine	0.000265	0.00216	CcSEcCtD
Metoclopramide—Palpitations—Verapamil—migraine	0.000263	0.00215	CcSEcCtD
Metoclopramide—Procainamide—SCN2A—migraine	0.000258	0.0396	CrCbGaD
Metoclopramide—Visual disturbance—Topiramate—migraine	0.000258	0.0021	CcSEcCtD
Metoclopramide—Convulsion—Verapamil—migraine	0.000258	0.0021	CcSEcCtD
Metoclopramide—Urticaria—Amitriptyline—migraine	0.000257	0.0021	CcSEcCtD
Metoclopramide—Hypertension—Verapamil—migraine	0.000257	0.0021	CcSEcCtD
Metoclopramide—Body temperature increased—Amitriptyline—migraine	0.000256	0.00209	CcSEcCtD
Metoclopramide—Agranulocytosis—Valproic Acid—migraine	0.000252	0.00206	CcSEcCtD
Metoclopramide—Asthma—Gabapentin—migraine	0.000251	0.00205	CcSEcCtD
Metoclopramide—Erectile dysfunction—Timolol—migraine	0.000248	0.00203	CcSEcCtD
Metoclopramide—Bronchospasm—Gabapentin—migraine	0.000247	0.00201	CcSEcCtD
Metoclopramide—Bradycardia—Valproic Acid—migraine	0.000246	0.00201	CcSEcCtD
Metoclopramide—Confusional state—Verapamil—migraine	0.000245	0.002	CcSEcCtD
Metoclopramide—Oedema—Verapamil—migraine	0.000243	0.00198	CcSEcCtD
Metoclopramide—Hallucination—Valproic Acid—migraine	0.000241	0.00197	CcSEcCtD
Metoclopramide—Depression—Timolol—migraine	0.000239	0.00196	CcSEcCtD
Metoclopramide—Insomnia—Propranolol—migraine	0.000239	0.00195	CcSEcCtD
Metoclopramide—Tachycardia—Verapamil—migraine	0.000237	0.00193	CcSEcCtD
Metoclopramide—Dyspnoea—Propranolol—migraine	0.000235	0.00192	CcSEcCtD
Metoclopramide—Somnolence—Propranolol—migraine	0.000234	0.00191	CcSEcCtD
Metoclopramide—Visual impairment—Valproic Acid—migraine	0.000233	0.00191	CcSEcCtD
Metoclopramide—CHRM1—head—migraine	0.000233	0.0158	CbGeAlD
Metoclopramide—Asthenia—Amitriptyline—migraine	0.000232	0.0019	CcSEcCtD
Metoclopramide—Pollakiuria—Gabapentin—migraine	0.000232	0.00189	CcSEcCtD
Metoclopramide—Erectile dysfunction—Gabapentin—migraine	0.000231	0.00189	CcSEcCtD
Metoclopramide—Fatigue—Propranolol—migraine	0.000227	0.00186	CcSEcCtD
Metoclopramide—Hypotension—Verapamil—migraine	0.000227	0.00185	CcSEcCtD
Metoclopramide—Agranulocytosis—Timolol—migraine	0.000224	0.00183	CcSEcCtD
Metoclopramide—Drowsiness—Gabapentin—migraine	0.000224	0.00183	CcSEcCtD
Metoclopramide—Depression—Gabapentin—migraine	0.000223	0.00182	CcSEcCtD
Metoclopramide—HTR3A—brain—migraine	0.000222	0.0151	CbGeAlD
Metoclopramide—Diarrhoea—Amitriptyline—migraine	0.000222	0.00181	CcSEcCtD
Metoclopramide—CHRM1—nervous system—migraine	0.000221	0.015	CbGeAlD
Metoclopramide—Insomnia—Verapamil—migraine	0.000219	0.00179	CcSEcCtD
Metoclopramide—Bradycardia—Timolol—migraine	0.000219	0.00179	CcSEcCtD
Metoclopramide—Jaundice—Gabapentin—migraine	0.000218	0.00178	CcSEcCtD
Metoclopramide—Dyspnoea—Verapamil—migraine	0.000216	0.00177	CcSEcCtD
Metoclopramide—Somnolence—Verapamil—migraine	0.000216	0.00176	CcSEcCtD
Metoclopramide—Hallucination—Timolol—migraine	0.000214	0.00175	CcSEcCtD
Metoclopramide—Dizziness—Amitriptyline—migraine	0.000214	0.00175	CcSEcCtD
Metoclopramide—Amisulpride—HTR2A—migraine	0.000214	0.0328	CrCbGaD
Metoclopramide—CHRM1—central nervous system—migraine	0.000213	0.0145	CbGeAlD
Metoclopramide—Asthma—Topiramate—migraine	0.000211	0.00172	CcSEcCtD
Metoclopramide—Urticaria—Propranolol—migraine	0.000209	0.00171	CcSEcCtD
Metoclopramide—Fatigue—Verapamil—migraine	0.000209	0.00171	CcSEcCtD
Metoclopramide—Body temperature increased—Propranolol—migraine	0.000208	0.0017	CcSEcCtD
Metoclopramide—Visual impairment—Timolol—migraine	0.000208	0.0017	CcSEcCtD
Metoclopramide—Nervousness—Valproic Acid—migraine	0.000205	0.00167	CcSEcCtD
Metoclopramide—Bradycardia—Gabapentin—migraine	0.000204	0.00167	CcSEcCtD
Metoclopramide—Rash—Amitriptyline—migraine	0.000204	0.00167	CcSEcCtD
Metoclopramide—Dermatitis—Amitriptyline—migraine	0.000204	0.00167	CcSEcCtD
Metoclopramide—CYP2D6—brainstem—migraine	0.000204	0.0139	CbGeAlD
Metoclopramide—Headache—Amitriptyline—migraine	0.000203	0.00166	CcSEcCtD
Metoclopramide—Muscle spasms—Valproic Acid—migraine	0.000203	0.00165	CcSEcCtD
Metoclopramide—Cisapride—HTR2C—migraine	0.000201	0.0309	CrCbGaD
Metoclopramide—Feeling abnormal—Verapamil—migraine	0.0002	0.00163	CcSEcCtD
Metoclopramide—Hallucination—Gabapentin—migraine	0.0002	0.00163	CcSEcCtD
Metoclopramide—Tremor—Valproic Acid—migraine	0.000197	0.00161	CcSEcCtD
Metoclopramide—Neutropenia—Topiramate—migraine	0.000197	0.00161	CcSEcCtD
Metoclopramide—Pollakiuria—Topiramate—migraine	0.000195	0.00159	CcSEcCtD
Metoclopramide—Hypersensitivity—Propranolol—migraine	0.000194	0.00159	CcSEcCtD
Metoclopramide—Erectile dysfunction—Topiramate—migraine	0.000194	0.00159	CcSEcCtD
Metoclopramide—Agitation—Valproic Acid—migraine	0.000194	0.00158	CcSEcCtD
Metoclopramide—Visual impairment—Gabapentin—migraine	0.000193	0.00158	CcSEcCtD
Metoclopramide—Urticaria—Verapamil—migraine	0.000193	0.00157	CcSEcCtD
Metoclopramide—Angioedema—Valproic Acid—migraine	0.000193	0.00157	CcSEcCtD
Metoclopramide—Nausea—Amitriptyline—migraine	0.000192	0.00157	CcSEcCtD
Metoclopramide—Asthenia—Propranolol—migraine	0.000189	0.00155	CcSEcCtD
Metoclopramide—Leukopenia—Valproic Acid—migraine	0.000189	0.00154	CcSEcCtD
Metoclopramide—Depression—Topiramate—migraine	0.000188	0.00153	CcSEcCtD
Metoclopramide—DRD2—head—migraine	0.000188	0.0128	CbGeAlD
Metoclopramide—Palpitations—Valproic Acid—migraine	0.000186	0.00152	CcSEcCtD
Metoclopramide—Nervousness—Timolol—migraine	0.000182	0.00149	CcSEcCtD
Metoclopramide—Hypertension—Valproic Acid—migraine	0.000182	0.00149	CcSEcCtD
Metoclopramide—Diarrhoea—Propranolol—migraine	0.00018	0.00147	CcSEcCtD
Metoclopramide—Anxiety—Valproic Acid—migraine	0.000179	0.00146	CcSEcCtD
Metoclopramide—Hypersensitivity—Verapamil—migraine	0.000179	0.00146	CcSEcCtD
Metoclopramide—DRD2—nervous system—migraine	0.000178	0.0121	CbGeAlD
Metoclopramide—Agranulocytosis—Topiramate—migraine	0.000176	0.00143	CcSEcCtD
Metoclopramide—Dizziness—Propranolol—migraine	0.000174	0.00142	CcSEcCtD
Metoclopramide—Asthenia—Verapamil—migraine	0.000174	0.00142	CcSEcCtD
Metoclopramide—Confusional state—Valproic Acid—migraine	0.000173	0.00142	CcSEcCtD
Metoclopramide—Oedema—Valproic Acid—migraine	0.000172	0.0014	CcSEcCtD
Metoclopramide—Bradycardia—Topiramate—migraine	0.000172	0.0014	CcSEcCtD
Metoclopramide—Angioedema—Timolol—migraine	0.000171	0.0014	CcSEcCtD
Metoclopramide—DRD2—central nervous system—migraine	0.000171	0.0116	CbGeAlD
Metoclopramide—Nervousness—Gabapentin—migraine	0.00017	0.00139	CcSEcCtD
Metoclopramide—CHRM1—brain—migraine	0.000169	0.0115	CbGeAlD
Metoclopramide—Hallucination—Topiramate—migraine	0.000168	0.00137	CcSEcCtD
Metoclopramide—Muscle spasms—Gabapentin—migraine	0.000168	0.00137	CcSEcCtD
Metoclopramide—Tachycardia—Valproic Acid—migraine	0.000168	0.00137	CcSEcCtD
Metoclopramide—DRD2—cerebellum—migraine	0.000167	0.0114	CbGeAlD
Metoclopramide—Rash—Propranolol—migraine	0.000166	0.00136	CcSEcCtD
Metoclopramide—Dermatitis—Propranolol—migraine	0.000166	0.00136	CcSEcCtD
Metoclopramide—Diarrhoea—Verapamil—migraine	0.000166	0.00136	CcSEcCtD
Metoclopramide—Palpitations—Timolol—migraine	0.000166	0.00135	CcSEcCtD
Metoclopramide—Tremor—Gabapentin—migraine	0.000164	0.00134	CcSEcCtD
Metoclopramide—Visual impairment—Topiramate—migraine	0.000163	0.00133	CcSEcCtD
Metoclopramide—Hypertension—Timolol—migraine	0.000162	0.00132	CcSEcCtD
Metoclopramide—Hypotension—Valproic Acid—migraine	0.000161	0.00131	CcSEcCtD
Metoclopramide—Agitation—Gabapentin—migraine	0.000161	0.00131	CcSEcCtD
Metoclopramide—Dizziness—Verapamil—migraine	0.00016	0.00131	CcSEcCtD
Metoclopramide—Angioedema—Gabapentin—migraine	0.00016	0.0013	CcSEcCtD
Metoclopramide—Anxiety—Timolol—migraine	0.000159	0.0013	CcSEcCtD
Metoclopramide—Flushing—Topiramate—migraine	0.000157	0.00128	CcSEcCtD
Metoclopramide—Nausea—Propranolol—migraine	0.000157	0.00128	CcSEcCtD
Metoclopramide—Leukopenia—Gabapentin—migraine	0.000156	0.00128	CcSEcCtD
Metoclopramide—Insomnia—Valproic Acid—migraine	0.000156	0.00127	CcSEcCtD
Metoclopramide—Palpitations—Gabapentin—migraine	0.000154	0.00126	CcSEcCtD
Metoclopramide—Confusional state—Timolol—migraine	0.000154	0.00126	CcSEcCtD
Metoclopramide—Dyspnoea—Valproic Acid—migraine	0.000153	0.00125	CcSEcCtD
Metoclopramide—Oedema—Timolol—migraine	0.000153	0.00125	CcSEcCtD
Metoclopramide—Rash—Verapamil—migraine	0.000153	0.00125	CcSEcCtD
Metoclopramide—Somnolence—Valproic Acid—migraine	0.000153	0.00125	CcSEcCtD
Metoclopramide—Dermatitis—Verapamil—migraine	0.000153	0.00125	CcSEcCtD
Metoclopramide—Headache—Verapamil—migraine	0.000152	0.00124	CcSEcCtD
Metoclopramide—Convulsion—Gabapentin—migraine	0.000151	0.00124	CcSEcCtD
Metoclopramide—Hypertension—Gabapentin—migraine	0.000151	0.00123	CcSEcCtD
Metoclopramide—Fatigue—Valproic Acid—migraine	0.000148	0.00121	CcSEcCtD
Metoclopramide—Anxiety—Gabapentin—migraine	0.000148	0.00121	CcSEcCtD
Metoclopramide—Nausea—Verapamil—migraine	0.000144	0.00118	CcSEcCtD
Metoclopramide—Confusional state—Gabapentin—migraine	0.000144	0.00117	CcSEcCtD
Metoclopramide—Hypotension—Timolol—migraine	0.000143	0.00117	CcSEcCtD
Metoclopramide—Nervousness—Topiramate—migraine	0.000143	0.00117	CcSEcCtD
Metoclopramide—Oedema—Gabapentin—migraine	0.000143	0.00116	CcSEcCtD
Metoclopramide—Feeling abnormal—Valproic Acid—migraine	0.000142	0.00116	CcSEcCtD
Metoclopramide—Muscle spasms—Topiramate—migraine	0.000141	0.00115	CcSEcCtD
Metoclopramide—Tachycardia—Gabapentin—migraine	0.000139	0.00114	CcSEcCtD
Metoclopramide—Insomnia—Timolol—migraine	0.000138	0.00113	CcSEcCtD
Metoclopramide—Tremor—Topiramate—migraine	0.000138	0.00112	CcSEcCtD
Metoclopramide—Urticaria—Valproic Acid—migraine	0.000137	0.00112	CcSEcCtD
Metoclopramide—Dyspnoea—Timolol—migraine	0.000137	0.00111	CcSEcCtD
Metoclopramide—Somnolence—Timolol—migraine	0.000136	0.00111	CcSEcCtD
Metoclopramide—Body temperature increased—Valproic Acid—migraine	0.000136	0.00111	CcSEcCtD
Metoclopramide—DRD2—brain—migraine	0.000136	0.00924	CbGeAlD
Metoclopramide—Agitation—Topiramate—migraine	0.000135	0.0011	CcSEcCtD
Metoclopramide—Hypotension—Gabapentin—migraine	0.000133	0.00109	CcSEcCtD
Metoclopramide—Fatigue—Timolol—migraine	0.000132	0.00108	CcSEcCtD
Metoclopramide—Leukopenia—Topiramate—migraine	0.000132	0.00107	CcSEcCtD
Metoclopramide—Palpitations—Topiramate—migraine	0.00013	0.00106	CcSEcCtD
Metoclopramide—Insomnia—Gabapentin—migraine	0.000129	0.00105	CcSEcCtD
Metoclopramide—Cisapride—HTR2A—migraine	0.000128	0.0197	CrCbGaD
Metoclopramide—Convulsion—Topiramate—migraine	0.000127	0.00104	CcSEcCtD
Metoclopramide—Dyspnoea—Gabapentin—migraine	0.000127	0.00104	CcSEcCtD
Metoclopramide—Hypertension—Topiramate—migraine	0.000127	0.00104	CcSEcCtD
Metoclopramide—Somnolence—Gabapentin—migraine	0.000127	0.00104	CcSEcCtD
Metoclopramide—Hypersensitivity—Valproic Acid—migraine	0.000127	0.00103	CcSEcCtD
Metoclopramide—Feeling abnormal—Timolol—migraine	0.000126	0.00103	CcSEcCtD
Metoclopramide—Anxiety—Topiramate—migraine	0.000125	0.00102	CcSEcCtD
Metoclopramide—Asthenia—Valproic Acid—migraine	0.000123	0.00101	CcSEcCtD
Metoclopramide—Fatigue—Gabapentin—migraine	0.000123	0.001	CcSEcCtD
Metoclopramide—Urticaria—Timolol—migraine	0.000122	0.000993	CcSEcCtD
Metoclopramide—Body temperature increased—Timolol—migraine	0.000121	0.000989	CcSEcCtD
Metoclopramide—Confusional state—Topiramate—migraine	0.000121	0.000988	CcSEcCtD
Metoclopramide—Oedema—Topiramate—migraine	0.00012	0.00098	CcSEcCtD
Metoclopramide—Diarrhoea—Valproic Acid—migraine	0.000118	0.000961	CcSEcCtD
Metoclopramide—Feeling abnormal—Gabapentin—migraine	0.000118	0.00096	CcSEcCtD
Metoclopramide—Tachycardia—Topiramate—migraine	0.000117	0.000956	CcSEcCtD
Metoclopramide—Dizziness—Valproic Acid—migraine	0.000114	0.000929	CcSEcCtD
Metoclopramide—Urticaria—Gabapentin—migraine	0.000113	0.000925	CcSEcCtD
Metoclopramide—Hypersensitivity—Timolol—migraine	0.000113	0.000921	CcSEcCtD
Metoclopramide—Body temperature increased—Gabapentin—migraine	0.000113	0.000921	CcSEcCtD
Metoclopramide—CYP2D6—head—migraine	0.000113	0.00766	CbGeAlD
Metoclopramide—Hypotension—Topiramate—migraine	0.000112	0.000915	CcSEcCtD
Metoclopramide—Asthenia—Timolol—migraine	0.00011	0.000897	CcSEcCtD
Metoclopramide—Insomnia—Topiramate—migraine	0.000109	0.000886	CcSEcCtD
Metoclopramide—Rash—Valproic Acid—migraine	0.000108	0.000886	CcSEcCtD
Metoclopramide—Dermatitis—Valproic Acid—migraine	0.000108	0.000885	CcSEcCtD
Metoclopramide—Headache—Valproic Acid—migraine	0.000108	0.00088	CcSEcCtD
Metoclopramide—Dyspnoea—Topiramate—migraine	0.000107	0.000873	CcSEcCtD
Metoclopramide—CYP2D6—nervous system—migraine	0.000107	0.00726	CbGeAlD
Metoclopramide—Somnolence—Topiramate—migraine	0.000107	0.000871	CcSEcCtD
Metoclopramide—Hypersensitivity—Gabapentin—migraine	0.000105	0.000858	CcSEcCtD
Metoclopramide—Diarrhoea—Timolol—migraine	0.000105	0.000856	CcSEcCtD
Metoclopramide—Fatigue—Topiramate—migraine	0.000103	0.000845	CcSEcCtD
Metoclopramide—CYP2D6—central nervous system—migraine	0.000103	0.00699	CbGeAlD
Metoclopramide—Asthenia—Gabapentin—migraine	0.000102	0.000836	CcSEcCtD
Metoclopramide—Nausea—Valproic Acid—migraine	0.000102	0.000834	CcSEcCtD
Metoclopramide—Dizziness—Timolol—migraine	0.000101	0.000827	CcSEcCtD
Metoclopramide—CYP2D6—cerebellum—migraine	0.000101	0.00684	CbGeAlD
Metoclopramide—Feeling abnormal—Topiramate—migraine	9.89e-05	0.000807	CcSEcCtD
Metoclopramide—Diarrhoea—Gabapentin—migraine	9.76e-05	0.000797	CcSEcCtD
Metoclopramide—Rash—Timolol—migraine	9.65e-05	0.000788	CcSEcCtD
Metoclopramide—Dermatitis—Timolol—migraine	9.65e-05	0.000788	CcSEcCtD
Metoclopramide—Headache—Timolol—migraine	9.59e-05	0.000783	CcSEcCtD
Metoclopramide—Urticaria—Topiramate—migraine	9.53e-05	0.000778	CcSEcCtD
Metoclopramide—Body temperature increased—Topiramate—migraine	9.48e-05	0.000774	CcSEcCtD
Metoclopramide—Dizziness—Gabapentin—migraine	9.43e-05	0.00077	CcSEcCtD
Metoclopramide—Nausea—Timolol—migraine	9.09e-05	0.000743	CcSEcCtD
Metoclopramide—Rash—Gabapentin—migraine	8.99e-05	0.000734	CcSEcCtD
Metoclopramide—Dermatitis—Gabapentin—migraine	8.98e-05	0.000734	CcSEcCtD
Metoclopramide—Headache—Gabapentin—migraine	8.93e-05	0.00073	CcSEcCtD
Metoclopramide—Hypersensitivity—Topiramate—migraine	8.84e-05	0.000722	CcSEcCtD
Metoclopramide—Asthenia—Topiramate—migraine	8.61e-05	0.000703	CcSEcCtD
Metoclopramide—Nausea—Gabapentin—migraine	8.47e-05	0.000692	CcSEcCtD
Metoclopramide—Diarrhoea—Topiramate—migraine	8.21e-05	0.00067	CcSEcCtD
Metoclopramide—CYP2D6—brain—migraine	8.17e-05	0.00555	CbGeAlD
Metoclopramide—HTR4—Signaling by GPCR—TAC1—migraine	8.12e-05	0.000875	CbGpPWpGaD
Metoclopramide—DRD2—Circadian rythm related genes—SLC6A4—migraine	8.12e-05	0.000874	CbGpPWpGaD
Metoclopramide—CHRM1—Circadian rythm related genes—NPS—migraine	8.1e-05	0.000873	CbGpPWpGaD
Metoclopramide—DRD3—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	8.01e-05	0.000863	CbGpPWpGaD
Metoclopramide—HTR4—Signaling by GPCR—HTR2C—migraine	7.97e-05	0.000858	CbGpPWpGaD
Metoclopramide—CHRM1—Circadian rythm related genes—SLC6A4—migraine	7.95e-05	0.000856	CbGpPWpGaD
Metoclopramide—Dizziness—Topiramate—migraine	7.93e-05	0.000648	CcSEcCtD
Metoclopramide—DRD3—GPCR downstream signaling—RAMP1—migraine	7.83e-05	0.000843	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—CALCRL—migraine	7.83e-05	0.000843	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism—CACNA1A—migraine	7.79e-05	0.000839	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—HTR2B—migraine	7.77e-05	0.000837	CbGpPWpGaD
Metoclopramide—HTR4—Signaling by GPCR—EDNRA—migraine	7.75e-05	0.000835	CbGpPWpGaD
Metoclopramide—DRD3—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	7.71e-05	0.00083	CbGpPWpGaD
Metoclopramide—DRD2—G alpha (i) signalling events—HTR1B—migraine	7.71e-05	0.00083	CbGpPWpGaD
Metoclopramide—DRD2—GPCR ligand binding—HTR1D—migraine	7.7e-05	0.00083	CbGpPWpGaD
Metoclopramide—HTR4—GPCR downstream signaling—HTR7—migraine	7.68e-05	0.000828	CbGpPWpGaD
Metoclopramide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—migraine	7.68e-05	0.000827	CbGpPWpGaD
Metoclopramide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—migraine	7.68e-05	0.000827	CbGpPWpGaD
Metoclopramide—DRD3—GPCRs, Class A Rhodopsin-like—HTR7—migraine	7.61e-05	0.00082	CbGpPWpGaD
Metoclopramide—DRD3—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	7.59e-05	0.000818	CbGpPWpGaD
Metoclopramide—DRD3—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	7.59e-05	0.000818	CbGpPWpGaD
Metoclopramide—Rash—Topiramate—migraine	7.56e-05	0.000618	CcSEcCtD
Metoclopramide—Dermatitis—Topiramate—migraine	7.56e-05	0.000617	CcSEcCtD
Metoclopramide—CHRM1—GPCR ligand binding—HTR1D—migraine	7.54e-05	0.000812	CbGpPWpGaD
Metoclopramide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2C—migraine	7.53e-05	0.000811	CbGpPWpGaD
Metoclopramide—Headache—Topiramate—migraine	7.52e-05	0.000614	CcSEcCtD
Metoclopramide—HTR4—Signaling by GPCR—CALCA—migraine	7.46e-05	0.000804	CbGpPWpGaD
Metoclopramide—DRD3—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	7.44e-05	0.000802	CbGpPWpGaD
Metoclopramide—DRD2—G alpha (i) signalling events—HTR1A—migraine	7.42e-05	0.000799	CbGpPWpGaD
Metoclopramide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EDNRA—migraine	7.32e-05	0.000789	CbGpPWpGaD
Metoclopramide—DRD3—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	7.24e-05	0.00078	CbGpPWpGaD
Metoclopramide—DRD2—GPCR ligand binding—HTR2B—migraine	7.16e-05	0.000771	CbGpPWpGaD
Metoclopramide—DRD2—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	7.15e-05	0.00077	CbGpPWpGaD
Metoclopramide—Nausea—Topiramate—migraine	7.13e-05	0.000582	CcSEcCtD
Metoclopramide—DRD2—Circadian rythm related genes—HTR7—migraine	7.11e-05	0.000766	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—RAMP1—migraine	7.11e-05	0.000766	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—CALCRL—migraine	7.11e-05	0.000766	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR ligand binding—HTR2B—migraine	7.01e-05	0.000755	CbGpPWpGaD
Metoclopramide—CHRM1—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	7e-05	0.000754	CbGpPWpGaD
Metoclopramide—HTR4—Signaling by GPCR—HTR7—migraine	6.98e-05	0.000752	CbGpPWpGaD
Metoclopramide—CHRM1—Circadian rythm related genes—HTR7—migraine	6.96e-05	0.00075	CbGpPWpGaD
Metoclopramide—DRD2—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	6.88e-05	0.000742	CbGpPWpGaD
Metoclopramide—HTR3A—SIDS Susceptibility Pathways—TNF—migraine	6.87e-05	0.00074	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—LRP1—migraine	6.84e-05	0.000737	CbGpPWpGaD
Metoclopramide—CHRM1—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	6.74e-05	0.000726	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism—CACNA1A—migraine	6.72e-05	0.000723	CbGpPWpGaD
Metoclopramide—DRD2—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	6.65e-05	0.000716	CbGpPWpGaD
Metoclopramide—DRD3—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	6.52e-05	0.000702	CbGpPWpGaD
Metoclopramide—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	6.51e-05	0.000701	CbGpPWpGaD
Metoclopramide—DRD2—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	6.47e-05	0.000697	CbGpPWpGaD
Metoclopramide—CHRM1—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	6.33e-05	0.000682	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—CACNA1A—migraine	6.28e-05	0.000677	CbGpPWpGaD
Metoclopramide—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	6.13e-05	0.00066	CbGpPWpGaD
Metoclopramide—DRD3—GPCR ligand binding—HTR1B—migraine	6.1e-05	0.000657	CbGpPWpGaD
Metoclopramide—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	6e-05	0.000646	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—RAMP1—migraine	5.99e-05	0.000645	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—CALCRL—migraine	5.99e-05	0.000645	CbGpPWpGaD
Metoclopramide—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	5.9e-05	0.000635	CbGpPWpGaD
Metoclopramide—DRD3—GPCR ligand binding—HTR1A—migraine	5.87e-05	0.000632	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—CALCRL—migraine	5.86e-05	0.000631	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—RAMP1—migraine	5.86e-05	0.000631	CbGpPWpGaD
Metoclopramide—DRD2—GPCRs, Class A Rhodopsin-like—HTR7—migraine	5.82e-05	0.000627	CbGpPWpGaD
Metoclopramide—DRD2—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	5.81e-05	0.000626	CbGpPWpGaD
Metoclopramide—DRD2—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	5.81e-05	0.000626	CbGpPWpGaD
Metoclopramide—DRD3—GPCR ligand binding—NPS—migraine	5.78e-05	0.000623	CbGpPWpGaD
Metoclopramide—DRD3—GPCR ligand binding—TAC1—migraine	5.78e-05	0.000623	CbGpPWpGaD
Metoclopramide—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	5.77e-05	0.000622	CbGpPWpGaD
Metoclopramide—CHRM1—GPCRs, Class A Rhodopsin-like—HTR7—migraine	5.7e-05	0.000614	CbGpPWpGaD
Metoclopramide—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	5.7e-05	0.000614	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—HTR1D—migraine	5.69e-05	0.000613	CbGpPWpGaD
Metoclopramide—CHRM1—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	5.68e-05	0.000612	CbGpPWpGaD
Metoclopramide—CHRM1—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	5.68e-05	0.000612	CbGpPWpGaD
Metoclopramide—DRD3—GPCR ligand binding—HTR2C—migraine	5.67e-05	0.000611	CbGpPWpGaD
Metoclopramide—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	5.57e-05	0.0006	CbGpPWpGaD
Metoclopramide—DRD2—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	5.54e-05	0.000597	CbGpPWpGaD
Metoclopramide—DRD3—GPCR ligand binding—EDNRA—migraine	5.51e-05	0.000594	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—CALCRL—migraine	5.44e-05	0.000586	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—RAMP1—migraine	5.44e-05	0.000586	CbGpPWpGaD
Metoclopramide—CHRM1—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	5.42e-05	0.000584	CbGpPWpGaD
Metoclopramide—HTR4—GPCR downstream signaling—HTR2A—migraine	5.38e-05	0.00058	CbGpPWpGaD
Metoclopramide—DRD3—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	5.33e-05	0.000574	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—CALCRL—migraine	5.32e-05	0.000573	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—RAMP1—migraine	5.32e-05	0.000573	CbGpPWpGaD
Metoclopramide—DRD3—GPCR ligand binding—CALCA—migraine	5.31e-05	0.000572	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—HTR2B—migraine	5.29e-05	0.00057	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—NOTCH4—migraine	5.25e-05	0.000565	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—HTR1D—migraine	5.16e-05	0.000556	CbGpPWpGaD
Metoclopramide—CHRM1—G alpha (q) signalling events—HTR2A—migraine	5.16e-05	0.000556	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—HTR1B—migraine	5.06e-05	0.000545	CbGpPWpGaD
Metoclopramide—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	4.99e-05	0.000537	CbGpPWpGaD
Metoclopramide—DRD3—GPCR ligand binding—HTR7—migraine	4.97e-05	0.000535	CbGpPWpGaD
Metoclopramide—HTR4—Signaling by GPCR—HTR2A—migraine	4.89e-05	0.000526	CbGpPWpGaD
Metoclopramide—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	4.88e-05	0.000526	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—HTR1A—migraine	4.87e-05	0.000525	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—HTR2B—migraine	4.8e-05	0.000517	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—NPS—migraine	4.8e-05	0.000517	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—PGR—migraine	4.8e-05	0.000517	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—TAC1—migraine	4.8e-05	0.000517	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—HTR2C—migraine	4.71e-05	0.000507	CbGpPWpGaD
Metoclopramide—DRD2—GPCR ligand binding—HTR1B—migraine	4.67e-05	0.000503	CbGpPWpGaD
Metoclopramide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—migraine	4.62e-05	0.000497	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—EDNRA—migraine	4.58e-05	0.000493	CbGpPWpGaD
Metoclopramide—DRD3—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	4.57e-05	0.000492	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR ligand binding—HTR1B—migraine	4.57e-05	0.000492	CbGpPWpGaD
Metoclopramide—DRD2—GPCR ligand binding—HTR1A—migraine	4.49e-05	0.000484	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—NOTCH3—migraine	4.46e-05	0.000481	CbGpPWpGaD
Metoclopramide—DRD2—GPCR ligand binding—NPS—migraine	4.42e-05	0.000476	CbGpPWpGaD
Metoclopramide—DRD2—GPCR ligand binding—TAC1—migraine	4.42e-05	0.000476	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—CALCA—migraine	4.41e-05	0.000475	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR ligand binding—HTR1A—migraine	4.4e-05	0.000473	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—HTR1D—migraine	4.35e-05	0.000469	CbGpPWpGaD
Metoclopramide—DRD2—GPCR ligand binding—HTR2C—migraine	4.34e-05	0.000467	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR ligand binding—NPS—migraine	4.33e-05	0.000466	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR ligand binding—TAC1—migraine	4.33e-05	0.000466	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—HTR1D—migraine	4.26e-05	0.000459	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR ligand binding—HTR2C—migraine	4.25e-05	0.000457	CbGpPWpGaD
Metoclopramide—DRD2—GPCR ligand binding—EDNRA—migraine	4.22e-05	0.000455	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—CALCRL—migraine	4.2e-05	0.000452	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—RAMP1—migraine	4.2e-05	0.000452	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR ligand binding—EDNRA—migraine	4.13e-05	0.000445	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—HTR7—migraine	4.12e-05	0.000444	CbGpPWpGaD
Metoclopramide—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	4.08e-05	0.000439	CbGpPWpGaD
Metoclopramide—DRD2—GPCR ligand binding—CALCA—migraine	4.06e-05	0.000438	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—HTR2B—migraine	4.05e-05	0.000436	CbGpPWpGaD
Metoclopramide—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	3.99e-05	0.00043	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR ligand binding—CALCA—migraine	3.98e-05	0.000428	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—HTR2B—migraine	3.96e-05	0.000427	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—HTR1D—migraine	3.95e-05	0.000426	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—HTR1D—migraine	3.87e-05	0.000417	CbGpPWpGaD
Metoclopramide—DRD2—GPCR ligand binding—HTR7—migraine	3.8e-05	0.000409	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR ligand binding—HTR7—migraine	3.72e-05	0.000401	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—HTR2B—migraine	3.67e-05	0.000396	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—HTR2B—migraine	3.6e-05	0.000387	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—TGFBR2—migraine	3.55e-05	0.000382	CbGpPWpGaD
Metoclopramide—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	3.49e-05	0.000376	CbGpPWpGaD
Metoclopramide—DRD3—GPCR ligand binding—HTR2A—migraine	3.48e-05	0.000375	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—HTR1B—migraine	3.45e-05	0.000371	CbGpPWpGaD
Metoclopramide—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	3.42e-05	0.000368	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—HTR1A—migraine	3.32e-05	0.000357	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—NPS—migraine	3.27e-05	0.000352	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—TAC1—migraine	3.27e-05	0.000352	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—CALCRL—migraine	3.21e-05	0.000346	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—RAMP1—migraine	3.21e-05	0.000346	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—HTR2C—migraine	3.2e-05	0.000345	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—CALCRL—migraine	3.14e-05	0.000339	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—RAMP1—migraine	3.14e-05	0.000339	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—HTR1B—migraine	3.13e-05	0.000337	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—EDNRA—migraine	3.12e-05	0.000336	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—HTR1D—migraine	3.05e-05	0.000329	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—HTR1A—migraine	3.01e-05	0.000324	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—CALCA—migraine	3e-05	0.000323	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—NPS—migraine	2.97e-05	0.00032	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—TAC1—migraine	2.97e-05	0.00032	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—HTR2C—migraine	2.91e-05	0.000313	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—HTR2A—migraine	2.89e-05	0.000311	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—HTR2B—migraine	2.84e-05	0.000306	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—EDNRA—migraine	2.83e-05	0.000305	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—HTR7—migraine	2.81e-05	0.000302	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—CALCA—migraine	2.72e-05	0.000293	CbGpPWpGaD
Metoclopramide—DRD2—GPCR ligand binding—HTR2A—migraine	2.66e-05	0.000287	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—HTR1B—migraine	2.64e-05	0.000284	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR ligand binding—HTR2A—migraine	2.6e-05	0.000281	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—HTR1B—migraine	2.58e-05	0.000278	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism—MTHFR—migraine	2.58e-05	0.000278	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—ESR1—migraine	2.56e-05	0.000276	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—HTR7—migraine	2.55e-05	0.000274	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—HTR1A—migraine	2.54e-05	0.000273	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—TAC1—migraine	2.5e-05	0.000269	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—NPS—migraine	2.5e-05	0.000269	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—LRP1—migraine	2.5e-05	0.000269	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—HTR1A—migraine	2.48e-05	0.000268	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—HTR2C—migraine	2.45e-05	0.000264	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—NPS—migraine	2.45e-05	0.000264	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—TAC1—migraine	2.45e-05	0.000264	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—HTR2C—migraine	2.4e-05	0.000258	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—HTR1B—migraine	2.39e-05	0.000258	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—EDNRA—migraine	2.38e-05	0.000257	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—HTR1B—migraine	2.34e-05	0.000252	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—HTR1D—migraine	2.33e-05	0.000251	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—EDNRA—migraine	2.33e-05	0.000251	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—HTR1A—migraine	2.3e-05	0.000248	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—CALCA—migraine	2.3e-05	0.000247	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—HTR1D—migraine	2.28e-05	0.000246	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—TAC1—migraine	2.27e-05	0.000245	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—NPS—migraine	2.27e-05	0.000245	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—HTR1A—migraine	2.26e-05	0.000243	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—CALCA—migraine	2.25e-05	0.000242	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—HTR2C—migraine	2.23e-05	0.00024	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism—MTHFR—migraine	2.22e-05	0.000239	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—TAC1—migraine	2.22e-05	0.000239	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—NPS—migraine	2.22e-05	0.000239	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—HTR2C—migraine	2.18e-05	0.000235	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—HTR2B—migraine	2.17e-05	0.000234	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—EDNRA—migraine	2.17e-05	0.000233	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—HTR7—migraine	2.15e-05	0.000231	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—HTR2B—migraine	2.12e-05	0.000229	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—EDNRA—migraine	2.12e-05	0.000228	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—HTR7—migraine	2.1e-05	0.000226	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—CALCA—migraine	2.08e-05	0.000225	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—MTHFR—migraine	2.08e-05	0.000224	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—CALCA—migraine	2.04e-05	0.00022	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—HTR2A—migraine	1.97e-05	0.000212	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—HTR7—migraine	1.95e-05	0.00021	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—NOTCH4—migraine	1.92e-05	0.000206	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—LRP1—migraine	1.91e-05	0.000206	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—HTR7—migraine	1.91e-05	0.000206	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—LRP1—migraine	1.87e-05	0.000201	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—HTR1B—migraine	1.85e-05	0.000199	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—HTR2A—migraine	1.78e-05	0.000192	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—HTR1A—migraine	1.78e-05	0.000192	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—TAC1—migraine	1.75e-05	0.000189	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—NPS—migraine	1.75e-05	0.000189	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—PGR—migraine	1.75e-05	0.000189	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—HTR2C—migraine	1.72e-05	0.000185	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—CACNA1A—migraine	1.7e-05	0.000183	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—EDNRA—migraine	1.67e-05	0.00018	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—NOTCH3—migraine	1.63e-05	0.000175	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—CALCA—migraine	1.61e-05	0.000173	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—HTR7—migraine	1.51e-05	0.000162	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—HTR2A—migraine	1.5e-05	0.000162	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—HTR2A—migraine	1.47e-05	0.000159	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—NOTCH4—migraine	1.47e-05	0.000158	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—NOTCH4—migraine	1.43e-05	0.000155	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—HTR1B—migraine	1.41e-05	0.000152	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—HTR1B—migraine	1.38e-05	0.000149	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—HTR2A—migraine	1.37e-05	0.000147	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—HTR1A—migraine	1.36e-05	0.000147	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—TAC1—migraine	1.34e-05	0.000144	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—NPS—migraine	1.34e-05	0.000144	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—PGR—migraine	1.34e-05	0.000144	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—HTR2A—migraine	1.34e-05	0.000144	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—HTR1A—migraine	1.33e-05	0.000144	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—HTR2C—migraine	1.31e-05	0.000142	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—TAC1—migraine	1.31e-05	0.000141	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—NPS—migraine	1.31e-05	0.000141	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—PGR—migraine	1.31e-05	0.000141	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—TGFBR2—migraine	1.3e-05	0.00014	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—HTR2C—migraine	1.29e-05	0.000139	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—EDNRA—migraine	1.28e-05	0.000138	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—EDNRA—migraine	1.25e-05	0.000135	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—NOTCH3—migraine	1.25e-05	0.000134	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—CALCA—migraine	1.23e-05	0.000133	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—NOTCH3—migraine	1.22e-05	0.000131	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—CALCA—migraine	1.21e-05	0.00013	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—HTR7—migraine	1.15e-05	0.000124	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—HTR7—migraine	1.13e-05	0.000121	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—HTR2A—migraine	1.05e-05	0.000114	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—TGFBR2—migraine	9.92e-06	0.000107	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—TGFBR2—migraine	9.71e-06	0.000105	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—ESR1—migraine	9.36e-06	0.000101	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—HTR2A—migraine	8.07e-06	8.69e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—HTR2A—migraine	7.89e-06	8.5e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—ESR1—migraine	7.16e-06	7.71e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—ESR1—migraine	7.01e-06	7.55e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—MTHFR—migraine	5.62e-06	6.05e-05	CbGpPWpGaD
